Melco Resorts (MLCO) reported Q1 2026 on May 7. It is the smallest of the four US-listed Macao concessionaires (≈$2.4B market cap) and the only one that has not participated in the 2025-2026 sector rerating. The question this filing crystallizes is whether MLCO's share-loss is cyclical or structural — and the answer has a calendar.

What the filing says. Macao GGR +10% YoY at MLCO; industry GGR +14.3%, industry VIP GGR +35.4%. The 4-percentage-point shortfall is the second consecutive quarter MLCO has trailed the sector. Adjusted property EBITDA +12% to ≈$381M, margins ≈28%. Three structural items emerged: (1) a $375M trademark purchase from parent Melco International eliminates an escalating royalty (1%→1.5% of revenues) for ≈$32-35M/yr net EBITDA accretion, with leverage staying under 0.5 turns and expected repaid by year-end; (2) a new $500M buyback authorization ($710M total) and year-end 2026 dividend target reaffirmed despite the trademark deal — only $14M deployed YTD; (3) Studio City REM hotel (149 suite-heavy keys) opens Q3 2026, MLCO's first new product since 2018.

Cross-ticker reads from peer Q1 calls show the other side. Sands China at 25.7% mass share, highest in two years; MGM +190bps March share. Sands Londoner Grand completed April 2025; MGM Cotai suite renovation completed pre-Golden Week 2026. Two operators — LVS (Patrick Dumont) and MLCO (Lawrence Ho) — independently flagged a Hormuz-driven Chinese long-haul cancellation tailwind to short-haul Macao (Air China + China Southern cut 2M+ seats; Macao Golden Week 873K visitors, +2.7%). MLCO management's framing that "competition just ticked up in Q1" is contradicted by LVS data showing reinvestment escalation began mid-2025 and stabilized two quarters ago — MLCO is reading its own environment nine months late.

What the market thinks. MLCO -0.8% over the past year vs LVS +40%, WYNN +30%, MGM +22%. P/E 9.4x vs peers 19.6-52.4x; EV/EBITDA ≈4.0-4.5x vs peers 10-13x. IV rank 100%, OTM put skew +31%, P/C OI 1.98 — the options market is paying for downside protection. Market-implied P(MLCO < $4) by Jan 2027 ≈ 19% versus our scenario weighting ≈ 10%.

Why the gap exists. Sell-side narratives discuss Macao share quarter-by-quarter without linking to product-cycle completion timing. Three operators have completed property cycles in the 12-18 months ending Q1 2026; MLCO has not until Q3 2026. The 50-percentage-point dispersion in YTD performance reflects this differential, but the explanatory frame — that the share war has a calendar — is not synthesized in coverage. MLCO idio variance is only ≈38.8%; the cross-ticker pattern lives in the relative trade, not the outright.

Risks (ranked). (1) REM execution slips past Q4 — the cyclical-vs-structural disambiguation becomes impossible before mid-2027. (2) Macao dividend tax substitution agreement non-renewal — sector-wide tail, affects all six concessionaires. (3) WYNN/Sands escalate reinvestment further, forcing MLCO to abandon discipline and compressing margins without share recovery.

Catalysts. WYNN Q1 2026 call after market close 2026-05-07 (reinvestment posture confirmation). DICJ April Macao GGR (+5.5% reported) and May data through mid-June. MLCO Q2 2026 print early August. REM phase-1 opening Q3 2026. Year-end 2026: dividend declaration and Macao tax extension confirmation.

What would change our mind. Q2 GGR gap narrowing below 2pp before REM opens (cyclical was already resolving). REM phase-1 slips past October (catalyst destroyed). MLCO suspends buyback or pushes dividend timeline (FCF degradation signal). WYNN tonight reveals reinvestment escalation across multiple operators (sector pattern, not idio).

Evidence